- Home
- INCY vs EWBC Comparison
INCY vs EWBC Comparison
Compare INCY & EWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCY
- EWBC
- Stock Information
- Founded
- INCY 1991
- EWBC 1998
- Country
- INCY United States
- EWBC United States
- Employees
- INCY N/A
- EWBC N/A
- Industry
- INCY Biotechnology: Commercial Physical & Biological Resarch
- EWBC Major Banks
- Sector
- INCY Health Care
- EWBC Finance
- Exchange
- INCY Nasdaq
- EWBC Nasdaq
- Market Cap
- INCY 16.1B
- EWBC 14.6B
- IPO Year
- INCY 1993
- EWBC 1999
- Fundamental
- Price
- INCY $86.85
- EWBC $106.51
- Analyst Decision
- INCY Buy
- EWBC Buy
- Analyst Count
- INCY 20
- EWBC 14
- Target Price
- INCY $80.67
- EWBC $120.14
- AVG Volume (30 Days)
- INCY 1.7M
- EWBC 996.5K
- Earning Date
- INCY 10-28-2025
- EWBC 10-21-2025
- Dividend Yield
- INCY N/A
- EWBC 2.26%
- EPS Growth
- INCY 900.04
- EWBC 9.78
- EPS
- INCY 4.37
- EWBC 8.56
- Revenue
- INCY $4,584,996,000.00
- EWBC $2,455,502,000.00
- Revenue This Year
- INCY $16.36
- EWBC $6.43
- Revenue Next Year
- INCY $10.82
- EWBC $4.57
- P/E Ratio
- INCY $19.80
- EWBC $12.41
- Revenue Growth
- INCY 18.87
- EWBC 4.10
- 52 Week Low
- INCY $53.56
- EWBC $68.27
- 52 Week High
- INCY $88.66
- EWBC $113.95
- Technical
- Relative Strength Index (RSI)
- INCY 59.41
- EWBC 50.23
- Support Level
- INCY $81.09
- EWBC $104.21
- Resistance Level
- INCY $88.66
- EWBC $109.44
- Average True Range (ATR)
- INCY 1.90
- EWBC 2.39
- MACD
- INCY 0.02
- EWBC -0.41
- Stochastic Oscillator
- INCY 76.09
- EWBC 37.40
About INCY Incyte Corp.
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
About EWBC East West Bancorp Inc.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.